rhIGF-1/rhIGFBP-3
Sponsors
Insmed Incorporated, Shire
Conditions
Noonan SyndromeRetinopathy of Prematurity (ROP)
Phase 2
Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
TerminatedNCT00351221
Target: 24Updated: 2007-03-30
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
CompletedNCT02386839
Start: 2015-03-26End: 2021-09-28Updated: 2022-05-18